JPRN-UMIN000007184
Completed
Phase 2
Phase2 study of limited Surgery for T1 or T2 lower rectal Cancer with adjuvant chemoradiotherapy - Limited Surgery for T1 or T2 lower rectal Cancer with adjuvant chemoradiotherapy
Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group0 sites50 target enrollmentMarch 1, 2012
ConditionsRectal cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Rectal cancer
- Sponsor
- Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Active synchronous or metachronous malignancy carcinoma in situ. 2\) Non\-treated radiotherapy 3\) Medical history of severe anaphylaxis or allergia to any drug. 4\) Severe diarrhea. 5\)Undergoing treatment with fluorocytosine. 6\) Severe complication. 7\) Pregnant or lactating woman at any time during study. Men of the fertility hope. 8\) Severe mental disorder. 9\) Patients judged inappropriate for the study by their physicians.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.Patients with synchronous or metachronous liver metastasis from gastric cancerJPRN-UMIN000011445Department of Surgery, Osaka University Graduate School of Medicine50
Recruiting
Phase 2
Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.(HiSCO 06)Patients with synchronous or metachronous liver metastasis from gastric cancerJPRN-UMIN000024004Hiroshima Surgical Study group of Clinical Oncology (HiSCO)30
Completed
Phase 2
A phase II feasibility study of surgical intervention for single station cN2 (UICC 6) non-small cell lung cancer (JNETS 0801)on-small cell lung cancerJPRN-UMIN000013247Japan North-East Area Thoracic Oncology Study Group34
Recruiting
Phase 2
A phase 2 study of the decision of surgical adjustment time based on IDRF (Image Defined Risk Factors), and chemotherapy that gradually improve strength for intermediate risk neuroblastomaintermediate risk neuroblastomasJPRN-UMIN000004700Japan Neuroblastoma Study Group73
Active, not recruiting
Phase 2
A phase 2 study for intermediate risk neuroblastoma based on IDRF (Image Defined Risk Factors)JPRN-jRCTs051180203iehara tomoko75